IMU 0.91% 5.5¢ imugene limited

Mimotopes, page-30

  1. 1,141 Posts.
    lightbulb Created with Sketch. 218
    Patentable immunoncology...
    Interesting..
    If u cant patent a treatment which cures cancer it has no real value..u cant make money!
    Herceptin has side effects, some degree of success and doesnt trigger ones own immune system best used with chemo.
    Nets 6 to 7 bill.
    Imagine a patentable cancer cure.few side effects..teaches the immune system to fight cancer hereonin and doesnt need chemo.
    Chemo by the way hopes to kill cancer cells before it kill the patient..very hit and miss.
    Imugenes product if succesful will be hugely advantages to big pharma..with its patents.
    Alternative practitioners of cancer already know of nitrilosides and laetrile compounds found in b17 which has a cyanide molecule which only is released by an enzyme found in cancer cells and is entirely operated by ones own immune system..works well....but has been banned in the us...cant buy vitamin b17...cyrious..i wonder why.
    Imugenes gonna be super valuable cos it mimics..roughly..laetrile and is patentable.
    And also mimotopes...both immune triggers...
    I read that eskimos and hunzas high b17 diet means no incidence...zero..of cancer in these societies.
    Im glad i a shareholder of imugene..this is gonna be one valuable company..oh...and go b17...!!
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
-0.001(0.91%)
Mkt cap ! $404.2M
Open High Low Value Volume
5.5¢ 5.6¢ 5.4¢ $289.8K 5.274M

Buyers (Bids)

No. Vol. Price($)
44 3713179 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 460941 17
View Market Depth
Last trade - 12.55pm 29/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.